US Stock MarketDetailed Quotes

MNPR Monopar Therapeutics

Watchlist
  • 20.7000
  • +1.2500+6.43%
Close Nov 27 16:00 ET
  • 19.6700
  • -1.0300-4.98%
Post 20:01 ET
109.25MMarket Cap-10454P/E (TTM)

Monopar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
44.66%-1.07M
20.21%-1.68M
27.11%-1.66M
-8.71%-7.86M
-18.75%-1.55M
9.71%-1.94M
-60.32%-2.1M
7.96%-2.27M
1.21%-7.23M
35.93%-1.3M
Net income from continuing operations
33.24%-1.3M
22.03%-1.72M
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
18.58%-1.95M
20.37%-2.2M
0.90%-2.43M
-15.52%-10.52M
-8.05%-2.9M
Change In working capital
106.88%31.65K
21.05%-295.88K
-9.62%-342.86K
-182.27%-1.35M
-117.17%-206.19K
-229.73%-460.22K
-134.23%-374.77K
38.74%-312.77K
417.93%1.65M
302.35%1.2M
-Change in payables and accrued expense
105.77%28.69K
6.99%-345.75K
-23.54%-311.24K
-190.21%-1.33M
-117.81%-213K
-79.04%-496.89K
-134.03%-371.72K
52.67%-251.92K
265.95%1.48M
251.09%1.2M
-Change in other current assets
-91.92%2.96K
1,735.65%49.87K
41.07%-35.86K
-111.88%-20.41K
-30.08%6.81K
-72.52%36.67K
-168.64%-3.05K
-352.35%-60.84K
299.26%171.76K
123.14%9.74K
-Change in other working capital
--0
--0
--4.24K
----
----
----
----
----
---4.24K
---4.49K
Cash from discontinued investing activities
Operating cash flow
44.66%-1.07M
20.21%-1.68M
27.11%-1.66M
-8.71%-7.86M
-18.75%-1.55M
9.71%-1.94M
-60.32%-2.1M
7.96%-2.27M
1.21%-7.23M
35.93%-1.3M
Investing cash flow
Cash flow from continuing investing activities
7,652.33%985.73K
-100.08%-2.42K
0.01%-983.31K
200.19%4.93M
160.39%2.97M
-13.05K
2.95M
-983.44K
-4.92M
-4.92M
Net investment purchase and sale
7,652.33%985.73K
-100.08%-2.42K
0.01%-983.31K
200.19%4.93M
160.39%2.97M
---13.05K
--2.95M
---983.44K
---4.92M
---4.92M
Cash from discontinued investing activities
Investing cash flow
7,652.33%985.73K
-100.08%-2.42K
0.01%-983.31K
200.19%4.93M
160.39%2.97M
---13.05K
--2.95M
---983.44K
---4.92M
---4.92M
Financing cash flow
Cash flow from continuing financing activities
-106.70%-16.53K
-101.55%-9.92K
295.36%3.18M
6,066.85%2.03M
141.14%334.55K
1,139.27%246.7K
1,079.50%641.18K
4,928.98%804.8K
-99.70%32.87K
1,885.09%138.74K
Net common stock issuance
--0
-100.00%-1
288.57%3.19M
1,797.07%2.07M
210.85%339.87K
--254.91K
--657.79K
--821.63K
-99.00%109.34K
--109.34K
Proceeds from stock option exercised by employees
--0
----
----
--0
--0
--0
----
----
-99.03%169
--0
Net other financing activities
-101.46%-16.53K
39.79%-10K
36.19%-10.74K
38.71%-46.97K
-118.10%-5.32K
65.61%-8.21K
74.64%-16.61K
-0.97%-16.83K
-21.15%-76.63K
478.28%29.4K
Cash from discontinued financing activities
Financing cash flow
-106.70%-16.53K
-101.55%-9.92K
295.36%3.18M
6,066.85%2.03M
141.14%334.55K
1,139.27%246.7K
1,079.50%641.18K
4,928.98%804.8K
-99.70%32.87K
1,885.09%138.74K
Net cash flow
Beginning cash position
-15.17%6.12M
36.36%7.81M
-11.24%7.27M
-59.68%8.19M
-61.48%5.52M
-56.18%7.21M
-67.87%5.73M
-59.68%8.19M
21.31%20.3M
-35.92%14.32M
Current changes in cash
93.89%-104.3K
-213.10%-1.69M
122.17%543.15K
92.54%-903.32K
128.92%1.76M
21.46%-1.71M
208.52%1.49M
1.39%-2.45M
-440.08%-12.11M
-198.16%-6.08M
Effect of exchange rate changes
-34.05%4.46K
134.27%1.49K
84.76%-1.65K
-382.92%-16.8K
82.84%-8.36K
-73.08%6.76K
-120.97%-4.35K
-1,545.37%-10.84K
-175.22%-3.48K
-2,556.46%-48.69K
End cash Position
9.15%6.02M
-15.17%6.12M
36.36%7.81M
-11.24%7.27M
-11.24%7.27M
-61.48%5.52M
-56.18%7.21M
-67.87%5.73M
-59.68%8.19M
-59.68%8.19M
Free cash flow
44.66%-1.07M
20.21%-1.68M
27.11%-1.66M
-8.71%-7.86M
-18.75%-1.55M
9.71%-1.94M
-60.32%-2.1M
7.96%-2.27M
1.21%-7.23M
35.93%-1.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 44.66%-1.07M20.21%-1.68M27.11%-1.66M-8.71%-7.86M-18.75%-1.55M9.71%-1.94M-60.32%-2.1M7.96%-2.27M1.21%-7.23M35.93%-1.3M
Net income from continuing operations 33.24%-1.3M22.03%-1.72M32.59%-1.64M20.10%-8.4M37.37%-1.81M18.58%-1.95M20.37%-2.2M0.90%-2.43M-15.52%-10.52M-8.05%-2.9M
Change In working capital 106.88%31.65K21.05%-295.88K-9.62%-342.86K-182.27%-1.35M-117.17%-206.19K-229.73%-460.22K-134.23%-374.77K38.74%-312.77K417.93%1.65M302.35%1.2M
-Change in payables and accrued expense 105.77%28.69K6.99%-345.75K-23.54%-311.24K-190.21%-1.33M-117.81%-213K-79.04%-496.89K-134.03%-371.72K52.67%-251.92K265.95%1.48M251.09%1.2M
-Change in other current assets -91.92%2.96K1,735.65%49.87K41.07%-35.86K-111.88%-20.41K-30.08%6.81K-72.52%36.67K-168.64%-3.05K-352.35%-60.84K299.26%171.76K123.14%9.74K
-Change in other working capital --0--0--4.24K-----------------------4.24K---4.49K
Cash from discontinued investing activities
Operating cash flow 44.66%-1.07M20.21%-1.68M27.11%-1.66M-8.71%-7.86M-18.75%-1.55M9.71%-1.94M-60.32%-2.1M7.96%-2.27M1.21%-7.23M35.93%-1.3M
Investing cash flow
Cash flow from continuing investing activities 7,652.33%985.73K-100.08%-2.42K0.01%-983.31K200.19%4.93M160.39%2.97M-13.05K2.95M-983.44K-4.92M-4.92M
Net investment purchase and sale 7,652.33%985.73K-100.08%-2.42K0.01%-983.31K200.19%4.93M160.39%2.97M---13.05K--2.95M---983.44K---4.92M---4.92M
Cash from discontinued investing activities
Investing cash flow 7,652.33%985.73K-100.08%-2.42K0.01%-983.31K200.19%4.93M160.39%2.97M---13.05K--2.95M---983.44K---4.92M---4.92M
Financing cash flow
Cash flow from continuing financing activities -106.70%-16.53K-101.55%-9.92K295.36%3.18M6,066.85%2.03M141.14%334.55K1,139.27%246.7K1,079.50%641.18K4,928.98%804.8K-99.70%32.87K1,885.09%138.74K
Net common stock issuance --0-100.00%-1288.57%3.19M1,797.07%2.07M210.85%339.87K--254.91K--657.79K--821.63K-99.00%109.34K--109.34K
Proceeds from stock option exercised by employees --0----------0--0--0---------99.03%169--0
Net other financing activities -101.46%-16.53K39.79%-10K36.19%-10.74K38.71%-46.97K-118.10%-5.32K65.61%-8.21K74.64%-16.61K-0.97%-16.83K-21.15%-76.63K478.28%29.4K
Cash from discontinued financing activities
Financing cash flow -106.70%-16.53K-101.55%-9.92K295.36%3.18M6,066.85%2.03M141.14%334.55K1,139.27%246.7K1,079.50%641.18K4,928.98%804.8K-99.70%32.87K1,885.09%138.74K
Net cash flow
Beginning cash position -15.17%6.12M36.36%7.81M-11.24%7.27M-59.68%8.19M-61.48%5.52M-56.18%7.21M-67.87%5.73M-59.68%8.19M21.31%20.3M-35.92%14.32M
Current changes in cash 93.89%-104.3K-213.10%-1.69M122.17%543.15K92.54%-903.32K128.92%1.76M21.46%-1.71M208.52%1.49M1.39%-2.45M-440.08%-12.11M-198.16%-6.08M
Effect of exchange rate changes -34.05%4.46K134.27%1.49K84.76%-1.65K-382.92%-16.8K82.84%-8.36K-73.08%6.76K-120.97%-4.35K-1,545.37%-10.84K-175.22%-3.48K-2,556.46%-48.69K
End cash Position 9.15%6.02M-15.17%6.12M36.36%7.81M-11.24%7.27M-11.24%7.27M-61.48%5.52M-56.18%7.21M-67.87%5.73M-59.68%8.19M-59.68%8.19M
Free cash flow 44.66%-1.07M20.21%-1.68M27.11%-1.66M-8.71%-7.86M-18.75%-1.55M9.71%-1.94M-60.32%-2.1M7.96%-2.27M1.21%-7.23M35.93%-1.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data